Recommended

Register now: Enhancing biopharma workflows with the power of UV/Vis spectroscopy webinar
Download our brand new eBook: A practical guide to single-use filtration in biopharma.
Join us as we look at how the outsourcing of buffers is helping biopharma drug manufacturers to streamline their processes.
Discover more on how Polpharma API meets evolving regulatory guidance around N-nitrosamines control in APIs with Waters’ high-performance analysis instruments.
Learn more about leveraging real-world data, the practical applications of AI and adopting configurable LC/NC solutions.
Download this compendium to discover how hot-melt extrusion can help to overcome pharmaceutical formulation challenges
article

Expert view: Mitigating risk with modern microbial identifications

Posted: 28 October 2020 | | No comments yet

Species-level microbial identification (ID) is a growing requirement under good manufacturing practice (GMP) to ensure patient safety.

However, this information can also benefit manufacturers. For example, understanding which species are present allows effective risk assessment of the product or during the manufacturing process, allowing for proactive action before a contamination event occurs.

    To read this expert view in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Charles River

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.